FDA confirms contaminate
The FDA is now confirming it has identified the contaminate in heparin as over-sulfated chondroitin sulfate. A rather effective and timely response from the agency considering the circumstances (see my post from this morning). According to the Wall Street Journal piece:
The FDA has also initiated testing of imported heparin entering this country and Ms. Woodcock said the agency feels “doctors and patients now can be confident that the product on the market has been tested and is safe.”
